Increased expression of P2RY2, CD248 and EphBl in gastric cancers from chilean patients

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 5, 2014, Pages 1931-1936

  Aquea, Gisela ^a   Bresky, Gustavo ^a   Lancellotti, Domingo ^a   Madariaga, Juan Andres ^a   Zaffiri, Vittorio ^a   Urzua, Ulises ^a   Haberle, Sergio ^b   Bernal, Giuliano ^a  

^a UNIVERSIDAD CATÓLICA DEL NORTE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

CD248; EphBl; Gastric cancer; Microarray; Molecular markers; P2RY2

Indexed keywords

CD248 PROTEIN, HUMAN; EPHRIN RECEPTOR B1; LEUKOCYTE ANTIGEN; MESSENGER RNA; P2RY2 PROTEIN, HUMAN; PURINERGIC P2Y2 RECEPTOR; TUMOR ANTIGEN; TUMOR MARKER;

CHILE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PROCEDURES; STOMACH TUMOR;

ANTIGENS, CD; ANTIGENS, NEOPLASM; CHILE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, EPHB1; RECEPTORS, PURINERGIC P2Y2; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899094827     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.5.1931     Document Type: Article

References (33)

1. Arancibia H, Carvajal C, Bustamante M, et al (2009). Quality of life of patients operated for gastric cancer. Rev Med Chile, 137, 481-6.
2. Bagley R, Rouleau C, St Martin T, et al (2008). Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Mol Cancer Ther, 7, 2536-46.
3. Bernal G (2012). Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer. Int J Biol Markers, 27, 82-9.
4. Bertazza L, Mocellin S, Marchet A, et al (2009). Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med, 7, 111-9.
5. Bouche E, Romero-Ortega M, Henkemeyer M, et al (2013). Reelin induces EphB activation. Cell Res, 23, 473-90.
6. Choi JH, Ji YG, Lee DH (2013). Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor. Pancreas, 42, 680-6.
7. Faria R, Ferreira L, Bezerra R, Frutuoso V, Alves L (2012). Action of natural products on P2 receptors: A reinvented era for drug discovery. Molecules, 17, 13009-25.
8. He C-Z, Zhang K-H (2013). Serum protein and genetic tumor markers of gastric carcinoma. Asian Pac J Cancer Prev, 14, 3437-42.
9. Heise K, Bertran E, Andia M, Ferreccio K (2009). Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol, 15, 185486.
10. Ingold B, Simon E, Ungethüm U, et al (2010). Vascular CXCR4 Expression a Novel Antiangiogenic Target in Gastric Cancer? PLoS ONE, 5, 10087.
11. Iwatsuki M, Mimori K , Fukagawa T, et al (2010) The Clinical Significance of Vimentin-Expressing Gastric Cancer Cells in Bone Marrow. Ann Surg Oncol, 17, 2526-33.
12. Kim SK, Jeon JW, Park JJ, et al (2011). Associations of EPHB1 polymorphisms with hepatocellular carcinoma in the Korean population. Hum Immunol, 72, 916-20.
13. Künzli B, Bernlochner MI, Rath S, et al (2011). Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signalling, 7, 231-41.
14. Li WH, Qiu Y, Zhang HQ, et al (2013). P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer, 109, 1666-75.
15. Li HJ, Wang LY, Qub HN, et al (2011). P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol Cell Endocrinol, 338, 28-37.
16. Ma G-J, Gu R-M, Zhu M, et al (2013). Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac J Cancer Prev, 14, 7551-4.
17. Maia M, DeVriese A, Janssens T, et al (2011). CD248 facilitates tumor growth via its cytoplasmic domain. BMC Cancer, 11, 162.
18. MINSAL (2010). Ministerio de Salud, Guia Clinica Cancer Gastrico. SERIE GUIAS CLINICAS MINSAL. 2° Edicion. Santiago. 8-9.
19. Naylor A, Azzam E, Smith S, et al (2012). The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice. Arthritis Rheum, 64, 3334-43.
20. Pesti S, Balázs A, Udupa R, et al (2012). Complex formation of EphB1/Nck/Caskin1 leads to tyrosine phosphorylation and structural changes of the Caskin1 SH3 domain. Cell Commun Signal, 10, 36.
21. Sampieri L, Pena S, Ochoa-Lara M, Zenteno-Cuevas R, Leon-Cordoba K (2010). Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis. World J Gastroenterol, 16, 1500-5.
22. Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S (2013). Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell, 24, 130-7.
23. Simonavicius N, Robertson D, Bax D, et al (2008). Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Modern Pathol, 21, 308-15.
24. Sisik A, Kaya M, Bas G, Basak F, Alimoglu O (2013). CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev, 14, 4289-94.
25. Valdez Y, Maia M, Conway EM (2012). CD248: reviewing its role in health and disease. Curr Drug Targets, 13, 432-9.
26. Wang F, Sun GP, Zou YF, et al (2012). MicroRNAs as promising biomarkers for gastric cáncer. Cancer Biomark, 11, 259-67.
27. Wang H, Wen J, Wang H et al (2014). Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival. Int J Clin Exp Pathol, 7, 313-21.
28. Wang JD, Dong Y C, Sheng Z, et al (2007). Loss of expression of EphB 1 protein in gastric carcinoma associated with invasion and metastasis. Oncology, 73, 238-45.
29. Xing YN, Yang X, Xu XY, et al (2011). The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression. Hum Pathol, 42, 25-35.
30. Yasui W, Sentani K, Sakamoto N, et al (2011). Molecular pathology of gastric cancer: research and practice. Pathol Res Pract, 207, 608-12
31. Yokobori T, Mimori K, Ishii H, et al (2010). Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. Ann Surg Oncol, 260, 2061-7.
32. Zhao ZS, Chu YQ, Ye ZY, Wang YY, Tao HQ (2010). Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol, 5, 686-96.
33. Zhang ZY, Zhang H, Adell G, Sun XF (2011). Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy. BMC Cancer, 11, 89.